Skip to main content
. 2013 Apr 23;8(4):e62691. doi: 10.1371/journal.pone.0062691

Table 1. Demographics of the Development and Validation cohorts.

Development cohort n = 253 Validation cohort n = 254 p
Female 100 (39.4%) 100 (39.5%) 0.97
Age, years 60.1±17.6 60.0±17.7 0.92
Weight, kg 79.9±18.3 78.4±18.4 0.40
APACHE II 17.7±6.3 18.2±6.6 0.44
SOFA 6.4±2.7 6.1±2.8 0.18
CKD (eGFR<60 ml/min) 44 (17.3%) 48 (19.0%) 0.63
Sepsis 48 (18.9%) 48 (19.0%) 0.98
Baseline plasma creatinine, mmol/L 0.076 (0.060–0.095) 0.075 (0.060–0.091) 0.59
eGFR 87 (67–108) 92 (67–114) 0.47
NGAL, ng/ml 97 (32–400) 83 (32–389) 0.84

Data presented as n(%), means ± sd, or median (interquartile range). APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; CKD: Chronic Kidney Disease; eGFR: estimated Glomerular Filtration Rate using the Modification of Diet in Renal Disease (MDRD) formula.